Next-generation clinical trial leadership
Principal Investigator · 78278343PCR3003 / KLK2-PASenger
Prof. Dr. Ahmet Dirican, MD, PhDMedical Oncology
Academic & scientific profile
My academic and clinical career has been shaped by a continuous commitment to integrating evidence-based oncology, scientific research, and emerging technologies into personalized cancer care.
Integrating advanced molecular profiling with real-world clinical value.
My academic and clinical career has been shaped by a continuous commitment to integrating evidence-based oncology, scientific research, and emerging technologies into personalized cancer care. My work focuses on translating advances in molecular oncology and innovative therapeutics into meaningful clinical strategies for patients.
Principal Investigator · 78278343PCR3003 / KLK2-PASenger
AMORE 2026, 13th Turkish Medical Oncology Congress, İzmir Uğur Yılmaz Oncology Days & XIII Rare Tumors Symposium
POLYDAMAS study
CodeBreaK and AMPLITUDE
Prof. Dr. Ahmet Dirican, MD, PhD began his medical career after graduating from Ege University Faculty of Medicine in 2001. Following his training in internal medicine, he completed his subspecialty training in medical oncology in 2013 and later earned a PhD in Basic Oncology at Dokuz Eylül University.
His academic and clinical work brings together patient care, medical education, Phase II–III clinical research, molecular profiling, and emerging cancer therapeutics. Since 2024, he has continued his practice as Professor of Medical Oncology at Medicana International İzmir Hospital.
His principal areas of interest include precision oncology, biomarker-driven treatment, next-generation sequencing, targeted therapies, immunotherapy, personalized cancer vaccines, and the careful translation of scientific innovation into clinical value.
Education & Academic Training
Academic & Clinical Career